Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Post by lscfaon Sep 03, 2016 11:57pm
211 Views
Post# 25206335

amended MD&A for annual results filed on sedar

amended MD&A for annual results filed on sedarAs  a result  of  a  review  by  the  Ontario  Securities Commission, this  MD&A  has  been amended August  31,  2016  in order  to provide  additional  information regarding the following:

•  The  definition  of  the  “Gross Basis Revenues”  as a non-IFRS  financial  measure under  “Non-IFRS Measures  –  Gross Basis Revenues” commencing  on  page 9;

•  Gross Basis Revenues  for  the Company’s  product  portfolio  in the  following  sections,  together with  a  reconciliation  to  revenues,  being  the nearest  IFRS  measure:

 “Results  of  Operations  for  the  Year  Ended  September  30,  2015  and  2014  –  Product Portfolio Revenues”,  commencing  on page  18;  and

 “Results  of  Operations  for  the  Three  Months  Ended  September  30, 2015 and  2014  – Product  Portfolio Revenues”, commencing  on page  23;

•  Additional  summary  financial  information  for  the  three  years  ended  September  30,  2015,  2014 and  2013, included  in the  summary  table  of  results  of  operations  and  financial  position  under “Results  of  Operations  for  the  Year  Ended September  30, 2015  and 2014”  on  page  17;

•  Additional  detailed  information  regarding  the  Company’s  Selling  and  Marketing  and General  and Administrative  operating  expenses  presented in  the  tables  included in the  following  sections:

o  “Results  of  Operations  for  the  Year  Ended  September  30, 2015  and  2014  –  Operating Expenses”,  commencing  on page  20;  and

o  “Results of  Operations for  the Three Months Ended  September  30, 2015 and  2014  – Operating  Expenses”, commencing  on page  25

•  Summary of  Quarterly  Results, on page  27;

•  Critical  Accounting  Policies, commending  on page  30;  and

• Financial Risk Management, commencing on page 34. 





<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse